Recent Headlines
Ostium Launch a Crowdfunding Campaign with IndieGoGo
Ostium makes it possible to detect illnesses at the stage of early functional disruptions, long before the onset of the first noticeable symptoms. Moreover, Ostium are able to predict, well in advance, many serious ailments, from asthma to tumors. Ostium Lab launch a crowdfunding campaign with IndieGoGo to continue their project, to improve the hardware and software complex, to process state registration and to launch mass production. - February 26, 2018 - Ostium
MCS System NGDS-1 Program Announced as a Finalist in the Medical/Dental Category for the 2018 Edison Awards
The Joint Project Management Office for Medical Countermeasure Systems (JPM-MCS) Next Generation Diagnostic System Increment 1 (NGDS Inc 1) program has been named a finalist in the Medical/Dental category for the 2018 Edison Awards. Established in 1987 and often described as “the Oscars of... - February 26, 2018 - JPM-MCS
Experimentica Ltd. Amongst the Most Promising Finnish Young Innovative Companies
Experimentica Ltd. has been selected for Phase 1 of the Young Innovative Company program by Business Finland (formerly known as TEKES, The Finnish Funding Agency for Technology and Innovation). The funding awarded for the first phase is a 250,000 € grant for a period of 12... - February 21, 2018 - Experimentica Ltd
Medical Evolutions 1 Inc. Rolls Out Direct to Consumer Comprehensive Pharmacogenomic Testing
Medical Evolutions 1 Inc. was established to educate the general public on becoming “empowered” in participating in their own healthcare along with their physician via the Medical Evolutions 1 Inc. Pharmacogenomic Comprehensive ME TEST™. The goal is to make the ordering and utilization of the test a simple, uncomplicated yet an effective process as well as making the test economically available to most. - February 21, 2018 - Medical Evolutions 1 Inc.
Perthera Inc. and Blue Faery Announce Their Partnership Against Liver Cancer
Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with Blue Faery, the leading Hepatocellular Carcinoma advocacy group in the US, with the goal to provide liver cancer patients with therapeutic treatment options precisely matched to their individual... - February 20, 2018 - Perthera, Inc.
Apostle Inc Appoints Alexander Hartemink, PhD at Duke University to Scientific Advisory Board
Apostle Inc is pleased to announce the appointment of Alexander J. Hartemink, PhD as a new member to its Scientific Advisory Board. Dr. Hartemink is Professor of Computer Science and Biology at Duke University. He is the faculty director of the Office of Undergraduate Scholars and Fellows and the... - February 19, 2018 - Apostle Inc
ASAlaser 2017: Double-Digit Growth of Turnover and Staff
Turnover has increased by 13% compared with 2016, staff has increased by 20%, 14% of investment in research and the launch of a new therapeutic solution: these are the figures of the year which has just ended for the company that has made laser therapy its flagship of excellence. The 2018 objective? Growth marked by internationalisation. - February 17, 2018 - ASA srl
Gordon Early, Wellness Family Medicine, Approved with TRICARE
Wellness Family Medicine in Spartanburg, South Carolina has been approved to accept TRICARE insurance. - February 13, 2018 - Wellness Family Medicine
Apostle Inc Appoints David B. Goldstein, PhD at Columbia University to Scientific Advisory Board
Apostle Inc is pleased to announce the appointment of David B. Goldstein, PhD as a new member to its Scientific Advisory Board. Dr. Goldstein is John E. Borne Professor of Medical and Surgical Research at Columbia University. - February 11, 2018 - Apostle Inc
Oxford Optronix Ltd. and Scintica Instrumentation Inc. Proudly Announce Agreement on Official Product Distribution for North America
With highly qualified sales and support staff covering both Canada and the United States and extensive expertise in supplying the life sciences with novel and high quality scientific instrumentation, Scintica is perfectly placed to partner with Oxford Optronix. The Scintica team consists of... - February 07, 2018 - Scintica Instrumentation
ReproTech, Ltd. Announces Collaboration with Fertility Preservation Trust
Latest innovation in cryostorage planning expand options for reproductive tissue disposition. - February 01, 2018 - ReproTech, LLC
Mopec Announces Addition of New Board Members
Mopec, an industry leading manufacturer and distributor of high quality pathology, anatomy, mortuary, and necropsy equipment and products, is pleased to announce the addition of Sally Brandtneris and Dr. Joyce deJong to the Company’s Board of Directors. - January 31, 2018 - Mopec
NanoHybrids Launches Revolutionary Contrast Agent to Measure EPR Effect at 2018 SPIE BiOS Expo
NanoHybrids, announces the launch of PAtrace, a proprietary nanoparticle that provides high resolution visualization and verification of the enhanced permeability and retention (EPR) effect in heterogeneous tumor models. PAtrace is being launched at the 2018 SPIE BioS Expo. - January 29, 2018 - NanoHybrids
Eagle Biosciences Introduces New Intact FGF23 ELISA Assay Kit
Eagle Biosciences, Inc. is proud to announce the launch of a new assay, MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit. MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit utilizes a simple 96 well sandwich ELISA procedure that measures ONLY the full-length active form (intact form) in under three hours. - January 26, 2018 - Eagle Biosciences, Inc.
Wake Research Welcomes Christine Heironimus as New Director of Business Development and Strategic Network Acceleration
Wake Research Welcomes Christine Heironimus as New Director of Business Development and Strategic Network Acceleration. - January 25, 2018 - Wake Research Associates
European Commission Approves Endoceutics’ Drug IntrarosaTM for the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
The European Commission has adopted the following on 8 January 2018: Adoption of Commission Implementing Decision granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for "Intrarosa - Prasterone," a medicinal product for human... - January 15, 2018 - Endoceutics
Research Square Announces Engaging New Multimedia Product, Video Bytes, to Share Research Results with the Public
Video Bytes are 1-minute summaries of published research that help scientists convey the importance of their work to the public. - January 12, 2018 - Research Square
A New Technique That Corrects Myopia (Nearsightedness) Has Been Developed by Dr. Antonio Medina at MIT and Several Medical Institutions Across the World
A patient’s cornea can be altered in a simple manner designed to correct myopia and other refractive errors. The Nature Journal Eye published in print the complete article by Antonio Medina as well as supplemental files that will aid those interested in using this new technology. The article is featured on the cover of the issue and titled, Plastic modification of the cornea by pneumatic force corrects myopia: Pneumatic Keratology Eye (2017) 31, 1621–1627 - December 31, 2017 - Antonio Medina
SARI Announced It Has Entered Into an Agreement to Acquire the 90% Interests in NMS Group
SARI is a Chinese market-leader biotech investment company. - December 30, 2017 - NMS Group
Internationally Renowned Tech Innovators and Investors Are Flocking to Cork for Beyond the Internet of Things Ground-Breaking Event Sponsored by SteriTrack Ltd
A new year and a new event looking beyond the new – Nimbus Research Centre, in collaboration with SteriTrack, are proud to host a ground-breaking event for 2018 “Beyond the Internet of Things – How to harness the next wave of digital technology and investment” at... - December 26, 2017 - Matrix Medical Tracking Systems
NanoHybrids Inc. Awarded NIH Grant to Advance Nanoparticle Enabled Photodynamic Therapy for Oral Cancer
NanoHybrids Inc. has been awarded $300,000 by the National Cancer Institute of the National Institutes of Health (NIH) through the Small Business Technology Transfer (STTR) program to enhance the therapeutic efficacy of photodynamic therapy (PDT) in oral cancers. - December 15, 2017 - NanoHybrids
Targeted Hyperthermia Treatment Accepted for Full Characterization at the Frederick National Laboratory for Cancer Research
Siva Therapeutics in partnership with NanoHybrids have teamed to develop and manufacture gold nanoparticles for treating cancer with hyperthermia. The nanoparticle treatment was submitted to the Frederick National Laboratory for Cancer Research and has passed the first stages in the Nanotechnology Characterization Laboratory, which helps pave the way for regulatory review of nanotechnologies intended for cancer therapies and diagnostics. - December 15, 2017 - NanoHybrids
Qualitative Identification of Synthetic Cannabinoids Using Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry (LC-QTOF/MS)
A presentation at the Southwestern Association of Toxicologists November 2017 scientific meeting in San Antonio, Texas highlighted the utility of Cayman’s Synthetic Cannabinoid Screening Library. This library is comprised of more than 350 synthetic cannabinoid standards, including parent... - December 14, 2017 - Cayman Chemical Company
International Society on Thrombosis and Haemostasis Selects City of London as 2022 Congress Location
The International Society on Thrombosis and Haemostasis (ISTH) today announced that the city of London has been selected as the location for the ISTH 2022 Congress. The official meeting dates will be announced in early 2018. “On behalf of the thrombosis and haemostasis community in the... - December 13, 2017 - International Society on Thrombosis and Haemostasis (ISTH)
Blue Diesel Data Science Introduces Pharmaceutical Insight Platform Reducing Research Time from Weeks to Minutes
Blue Diesel Data Science announces the beta launch of its pharmaceutical platform VisionaryRX. VisionaryRX provides a deep and comprehensive view into the drug industry. It relates multiple forms of industry standard data in the pharmaceutical industry under one view. Because VisionaryRX uses over 50 million rows of information, the result is fast and complete visibility into the industry. Useful for pharmaceutical manufacturing, labeling, partnerships and strategic direction insight. - December 10, 2017 - Blue Diesel Data Science
GeneFluidics Announces CE-IVD Marking of UtiMax™ Uropathogen Identification (ID) and Antimicrobial Susceptibility Testing (AST)
GeneFluidics, a molecular diagnostics company specializing in the development of diagnostics solutions for infectious diseases, today announced CE marking for UtiMax™ under the Directive 98/79/EC on in vitro diagnostic medical devices. UtiMax™has successfully completed a multicenter validation study and clinical testing. It does not require clinical isolates from urine cultures, enabling a rapid ID reporting in as short as 30 minutes and AST in 120 minutes for a positive ID result. - December 10, 2017 - GeneFluidics Inc.
Analyte Health Expands Market Leadership, Launches Health Test Express Brand
Health Test Express Makes At-Home Health Testing Available - December 02, 2017 - Analyte Health
Perthera and ZERO Announce the Decode Your Prostate Cancer Program
Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with ZERO, the leading nonprofit prostate cancer advocacy group in the USA, to form and launch the nationwide Decode Your Prostate Cancer program aimed to provide each prostate cancer patient with... - November 28, 2017 - Perthera, Inc.
Mopec Creates Cadaver Lifts with Adaptable, Clear Design That Exceeds Industry Standards
Mopec introduces new cadaver lift series that feature more versatility in design and performance. Created with the consumer in mind, each lift has an adjustable top with a simple structure, achieving a Mopec standard in efficiency. An enhanced mechanical system offers advanced technological... - November 24, 2017 - Mopec
Dr. Susan Love Research Foundation Joins GIVE Los Angeles Challenge to Win $15,000 from LA Magazine
End of year fundraiser to further innovative breast cancer research. - November 22, 2017 - Dr. Susan Love Research Foundation
Betty Abernathy, FNP, MSN Credentialed by United Healthcare
Nurse Betty has been approved as a provider for United Healthcare. - November 22, 2017 - Wellness Family Medicine
Dr. Ira Gordon Early Credentialed by TRICARE
Dr. Early, a physician with Wellness Family Medicine has been credentialed by TRICARE Insurance. - November 22, 2017 - Wellness Family Medicine
Dr. Gordon Early Approved with Medicaid
Gordon Early, MD with Wellness Family Medicine receives approval as a Medicaid provider. - November 20, 2017 - Wellness Family Medicine
Dr. Ira Gordon Early, Jr., MD Has Been Approved to Participate in the Cigna Network
Ira Gordon Early Jr., MD, MPH is now part of the Cigna Insurance Network. - November 19, 2017 - Wellness Family Medicine
Wellness Family Medicine Now Accepting Aetna Insurance
Dr. Gordon Early has been accepted to provide services for Aetna. - November 19, 2017 - Wellness Family Medicine
Dr. Ira Gordon Early of Wellness Family Medicine Accepting First Choice Insurance
Dr. Ira Gordon Early has been approved to offer services as part of the Select Health of SC Insurance program (First Choice) - November 19, 2017 - Wellness Family Medicine
Dr. Gordon Early Approved with WellCare of South Carolina Health Plans
Gordon Early, MD, MPH, FACOEM, physician with Wellness Family Medicine was approved as a provider with Wellcare. - November 19, 2017 - Wellness Family Medicine
Stool Bank in Asia Welcomes New Scientist
The Asia Microbiota Bank, the first stool bank in Hong Kong, expands the team by adding a new scientist to help lead research efforts on bacteria clusters unique to the Asian population. The scientific team uses next generation sequencing and strain level analysis to optimize Fecal Microbiota Transplantation (FMT) treatment outcomes in Asia. "We hope that the deep FMT data we are collecting from around Asia will help uncover key strains that influence intestinal health."-Co-Founder, Jon Chan - November 16, 2017 - Asia Microbiota Bank
The European Medicines Agency Accepts Marketing Authorisation Application for Intrarosa for the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
Endoceutics Inc., a private Quebec City based biopharma company, today announced that the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product IntrarosaTM, intended for the treatment of... - November 13, 2017 - Endoceutics
Wellness Family Medicine Now Accepts United Healthcare Insurance
Dr. Gordon Early has been approved with United Healthcare. - November 06, 2017 - Wellness Family Medicine
Baebies Announces Completion of $10 Million Series B Financing
Innovative Newborn Screening and Pediatric Testing Company Ships 2 Millionth Test - October 31, 2017 - Baebies, Inc.
Clinerion Expands the Global Coverage of Its Services in the Americas, Adding 60 Million Patients in North America via Partnership with Provisio Inc.
Clinerion has expanded its geographic coverage to include over 60 million patients in the USA, via a strategic partnership with Provisio Inc. Clinerion now has a truly global footprint for its services for clinical trial patient search and identification, and data generation for real-world evidence and market access activities. - October 30, 2017 - Clinerion
NASA’s James Webb Space Telescope is Now Hanging Out in a Vibration-Isolating "Hammock" Supported by Minus K's Negative-Stiffness Vibration Isolators
NASA’s James Webb Space Telescope, the replacement to the Hubble Space Telescope is Now Hanging Out in a Vibration-Isolating "Hammock" Supported by Minus K's Negative-Stiffness Vibration Isolators in Johnson Space Center's Vaccum Chamber A being tested. - October 28, 2017 - Minus K Technology Inc.
Mercodia Releases Unique Multiplex Assay in Collaboration with Quansys
Multiplex assays have been plagued by a lack of specificity and accuracy, with unreliable data as a result. However, a new multiplex assay has reached the US market. Mercodia, based in Sweden, has teamed-up with Quansys Biosciences, based in the US, to launch the AKURIO Islet Hormones multiplex assay, which measures four of the most notable hormones in pancreatic research: glucagon, insulin, C‑peptide and proinsulin. - October 27, 2017 - Mercodia AB
The Morgan Leary Vaughan Fund Receives Petit Family Foundation Grant in Support of Regional Conference on Necrotizing Enterocolitis
The Morgan Leary Vaughan Fund (Morgan’s Fund) recently received a $4,000.00 grant from The Petit Family Foundation in support of the inaugural “Speaking of NEC: Unplugged” event, a one-day regional conference focused on identifying practical solutions for reducing the devastating... - October 16, 2017 - The Morgan Leary Vaughan Fund, Inc.
ClinLab Grows: Life Sciences Staffing Firm Moves to Bigger HQ in Watertown, MA
ClinLab Staffing (www.clinlabstaffing.com), ranked among the fastest-growing private companies in Massachusetts by the Boston Business Journal, moved to its new headquarters at the Riverworks Innovation Center in the Charles River Mill District of Watertown Massachusetts, effectively doubling its... - October 12, 2017 - ClinLab Staffing
Wake Research Expands North American Presence to West Coast with Acquisition of Medical Center for Clinical Research – San Diego
Adds to Strategic Partnerships across Western and Southern United States - October 04, 2017 - Wake Research Associates
MappBio Announces Contracts with BARDA for ZMapp and Additional Filovirus Medical Countermeasures
Mapp Biopharmaceutical, Inc., announced today that it has been awarded a Project BioShield contract (HHSO100201700017C) of approximately $46 million by The Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at... - September 30, 2017 - Mapp Biopharmaceutical, Inc.
Harry Perkins Institute of Medical Research Develops New Drug to Supercharge Immune Cells in the Fight Against Cancer
A new cancer treatment with the dual ability to normalise tumour blood vessels and boost the body’s immune system, has been developed by researchers from the Harry Perkins Institute of Medical Research and The University of Western Australia. - September 28, 2017 - Harry Perkins Institute of Medical Research
The Morgan Leary Vaughan Fund Wins Health + Wellness Design Award
The Morgan Leary Vaughan Fund (Morgan’s Fund) is pleased to announce that it has received an award from Graphic Design USA (GDUSA). The "Speaking of NEC" brochure, created as a companion piece to the audio podcast series of the same name, has been recognized as part of GDUSA’s... - September 27, 2017 - The Morgan Leary Vaughan Fund, Inc.